Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal
Public ClinicalTrials.gov record NCT04070157. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Safety and Effectiveness of LUCEMYRA in the Treatment of Opioid Withdrawal During an Opioid Taper in Subjects With Chronic Non-Cancer Pain
Study identification
- NCT ID
- NCT04070157
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- USWM, LLC (dba US WorldMeds)
- Industry
- Enrollment
- 4 participants
Conditions and interventions
Conditions
Interventions
- Lofexidine Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 1, 2019
- Primary completion
- Nov 26, 2019
- Completion
- Nov 26, 2019
- Last update posted
- Oct 20, 2024
2019
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Westview Clinical Research, LLC | Placentia | California | 92870 | — |
| Vitamed Research | Rancho Mirage | California | 92270 | — |
| Gold Coast Research, LLC | Plantation | Florida | 33317 | — |
| Georgia Clinical Research, LLC | Lawrenceville | Georgia | 30044 | — |
| Injury Care Research | Boise | Idaho | 83713 | — |
| Global Scientific Innovations | Evansville | Indiana | 47714 | — |
| Integrated Clinical Trial Services, Inc. | West Des Moines | Iowa | 50265 | — |
| Neuroscience Research Center, LLC | Overland Park | Kansas | 66210 | — |
| Otrimed Corporation (Otrimed Clinical Research Center) | Edgewood | Kentucky | 41017 | — |
| University of Rochester | Rochester | New York | 14624 | — |
| Duke Innovation Pain Therapies Clinic at Brier Creek | Raleigh | North Carolina | 27617 | — |
| The Center for Clinical Research, LLC | Winston-Salem | North Carolina | 27103 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04070157, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2024 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04070157 live on ClinicalTrials.gov.